Plain-English translation of NCT06867952 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
This study doesn't follow the usual testing phases โ it may be an observational study or a different type of research.
This trial is testing whether Soloways (a form of vitamin K2) can help strengthen bones in people with osteopenia or osteoporosis. The study is designed for people who carry a specific genetic variant that may make standard vitamin D supplements less effective for them. Researchers believe this medication might work better for this particular group by helping calcium deposit properly in bones.
Some people's bodies don't respond well to standard vitamin D and calcium supplements because of their genes. This trial exists to see whether the medication might be a better option for these individuals, and to develop personalized treatment plans based on a person's genetic makeup rather than using a one-size-fits-all approach.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
You would take the medication (Soloways vitamin K2) along with standard vitamin D3 supplementation for the duration of the study while maintaining your regular diet and exercise habits. The study compares two groups: people with the specific gene variant and a control group without it, to see if the medication works differently for each group. You would need to visit the study site for genetic testing, bone density scans, and follow-up visits to monitor your bone health.
AI-generated summary from trial data ยท Jun 3, 2026 ยท Not medical advice
Russia